SEARCH · PubMed Health

Results for “SPOROTRICHOSIS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 109 records · Page 6Linked to original sources

PubMed1981

Development of experimental sporotrichosis in normal and modified animals.

The development of experimental sporotrichosis was examined in immunologically-disturbed mice. In the case of intracutaneous inoculation, the lesion in cyclophosphamide-treated mice enlarged strikingly up to 6 days, but at 12 days it was similar in size to that in non-treated mice. The lesion in irradiated mice developed slowly up to 12 days, but thereafter it developed promptly. In nude mice, the lesion was smallest during the development of the lesion. Histological examination showed that numerous organisms were present in the lesion of nude and irradiated mice. Intraperitoneal inoculation showed that dissemination of spores were easily induced in nude mice as compared with littermate mice. These results indicate an important role of cellular immunity in the defence mechanism of sporotrichosis.

Animals↗

PubMed1980

Subpopulation of lymphocytes in the infiltrate of experimental sporotrichosis.

Lymphocyte subpopulations of dermal infiltrated cells on experimental sporotrichosis of guinea pigs was performed. According to Tan's method, infected sites were incubated with collagenase and then mechanically disaggregated. The liberated cells were used for determination of lymphocytes subpopulation. The predominance of B cells was present on the inoculated site, compare with blood from control and inoculated animals. Thus, the present result suggests the important role of humoral immunity in the development of sporotrichosis lesion.

Animals↗

PubMed1982

Polymorphonuclear leukocyte chemotaxis in sporotrichosis.

A lesion of sporotrichosis shows a characteristic arrangement of the infiltrate in three zones: the central suppurative zone composed of polymorphonuclear leukocytes, the tuberculoid zone and the round cell zone. For investigating the pathomechanism of the suppurative zone formation, polymorphonuclear leukocyte chemotaxis to sporotrichin was assayed with the agarose plate method. Polymorphonuclear leukocytes in the patients with sporotrichosis showed an enhanced chemotactic index in comparison with that in the control subjects. However, there was no difference in non-specific chemotaxis to bacteria-derived substance between the patients and the control subjects.

Aged↗

PubMed1990

A case of sporotrichosis caused by two genetically different Sporothrix schenckii strains.

Two Sporothrix schenckii strains of different mitochondrial DNA restriction profiles were isolated from different cutaneous lesions in a 53 year-old woman with sporotrichosis. These results suggest that sporotrichosis can be simultaneously caused by two or more genetically different S. schenckii strains.

DNA, Fungal↗

PubMed1994

Efficacy of acute phase and maintenance therapy with itraconazole in an AIDS patient with sporotrichosis.

An AIDS patient with sporotrichosis who improved with itraconazole therapy after consecutive failure of ketoconazole, saturated solution of potassium iodide, fluconazole and amphotericin B is presented. In addition, long-term therapy with high doses of itraconazole was well tolerated and effective in avoiding relapse. Itraconazole may be suitable for use in HIV-infected patients with sporotrichosis, who probably require chronic suppressive therapy to prevent relapse of symptomatic disease.

AIDS-Related Opportunistic Infections↗

PubMed2000

[Sporotrichosis--fixed cutaneous and lymphocutaneous form].

Two patients were infected with sporotrichosis; one had the fixed cutaneous form, the other the lymphocutaneous form. Sporotrichosis schenckii was identified in both with a culture from a tissue biopsy. Both patients were successfully treated with itraconazole, one received 100 mg and the other 200 mg itraconazole daily over a 3 months period.

Adult↗

PubMed2004

Subcutaneous bilateral sporotrichosis: a rare presentation.

Sporotrichosis is the most common subcutaneous mycosis observed in Brazil as well as in different regions of the world. We report a rare case of sporotrichosis in a Caucasian male agricultural worker whose lesions occurred bilaterally and simultaneously on the upper limbs.

Adult↗

PubMed2005

Positive Montenegro skin test among patients with sporotrichosis in Rio De Janeiro.

We studied 52 patients with sporotrichosis confirmed by isolation of Sporothrix schenckii and reactivity to the Montenegro skin test (MST) during an ongoing outbreak of this mycosis in Rio de Janeiro. The objective was to emphasize the importance of parasitological confirmation and the possibility of incorrect diagnosis based on the lesion's appearance, epidemiological information, and immunological tests. The antigen used for the MST was conserved in either thimerosal 1:10,000 (group 1) or 0.4% phenol (group 2). Nineteen patients (39%) in group 1 and seven (12%) in group 2 presented an induration>or=10 mm (p<0.001). Sera from three patients (6.7%) reacted to indirect immunofluorescence (IIF) for leishmaniasis, while sera from 10 patients (22.2%) reacted to enzyme-linked immunosorbent assay (ELISA). Fifteen patients (28.8%) presented up to two lesions, with a predominance of ulcers. Forty-four patients (84.6%) were treated with itraconazole. In the differential diagnosis between sporotrichosis and cutaneous leishmaniasis, the possibility of co-infection, allergy to the reagent diluent, and cross-reactions should be further investigated, especially in regions with limited laboratory facilities.

Adolescent↗

PubMed2005

Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis.

Sporotrichosis is a chronic granulomatous mycosis caused by the dimorphic fungus Sporothrix schenckii, which is widely distributed in nature, and presents a saprophytic mycelial form on plant debris and soil. The immunological mechanisms involved in the prevention and control of sporotrichosis are not yet fully understood. In this study, mice were studied after infection with Sporothrix schenckii. In the first week after infection, fungal loading increased and thence decreased drastically 14 days after infection. Analysis by immunoblotting showed that the sera of all mice tested had antibodies reacting only with a 70 kDa antigen, with predominance of IgG1 and IgG3. Taken together, our results show that antigens from S. schenckii induced a specific humoral response in infected mice.

Animals↗

PubMed1977

Primary pulmonary sporotrichosis.

A patient with primary pulmonary sporotrichosis with infiltration and cavitation is reported. Treatment for one year with potassium iodide resulted in marked resolution of the inflammatory lesions but persistent cavitation and fungal infection. Cure followed bisegmental lung resection with no recurrence during eight-year follow-up. Excellent results are reported in 10 patients treated by resection despite less then optimal preoperative iodide therapy. Surgical treatment of primary sporotrichosis with cavitation is indicated and should be unattended by complications or recurrence.

Adult↗

PubMed2003

Laryngeal sporotrichosis causing stridor in a young child.

Fungal infections of the larynx are rare entities that must be considered in the differential diagnosis of the patient who presents with laryngeal symptoms. We present an unusual case of initially recurrent and then persistent stridor in a 19-month-old girl, unresponsive to 4 months of antibiotic and steroid therapy. Upon our laryngoscopic examination, the patient was noted to have an ulcerated, granulomatous process involving the larynx. She also had an erythematous papule on the left thigh. Fungal cultures of both sites grew Sporothrix schenckii. The patient was treated with systemic antifungal medications and had complete resolution of her symptoms. We discuss the pathophysiology and possible source of this unusual form of sporotrichosis, the first such case reported in a child. We emphasize the role of empiric steroid therapy in exacerbating and eventually enabling dissemination of the infection. We also review the manifestations of sporotrichosis infections of the head and neck. This case demonstrates the vital importance of careful diagnosis and proper treatment of stridor in children.

Anti-Inflammatory Agents↗

PubMed1985

Fixed cutaneous sporotrichosis: unusual histopathology following intralesional corticosteroid administration.

The fixed cutaneous type of sporotrichosis is difficult to diagnose because clinical lesions are variable in appearance and the cells of Sporothrix schenckii are usually scarce in skin biopsy specimens. We have described two patients with lesions of fixed cutaneous sporotrichosis that resembled other inflammatory skin conditions and were treated with intralesional corticosteroids. Subsequent skin biopsies from these lesions demonstrated an unusually large number of yeast cells.

Adrenal Cortex Hormones↗

PubMed1989

Sporotrichosis in a father and son.

A 41-year-old man developed classic lymphocutaneous sporotrichosis on the left arm; his 2-year-old son developed a single lesion of the "fixed" type on the right leg. Both patients responded rapidly to therapy with oral potassium iodide. Seven previous reports of familial sporotrichosis are listed, and therapy is reviewed briefly.

Adult↗

PubMed1989

Sporotrichosis in the acquired immunodeficiency syndrome.

Kaposi's sarcoma and disseminated sporotrichosis of the skin and joints developed simultaneously in a homosexual man with antibodies to human immunodeficiency virus. There was no identified source of exposure to Sporothrix organisms. Sporotrichosis may be a presenting opportunistic infection associated with acquired immunodeficiency syndrome and tends to be disseminated at the time of diagnosis.

Acquired Immunodeficiency Syndrome↗

PubMed1998

Lymphangitic sporotrichosis: an uncommon bilateral localization.

Sporotrichosis is a mycotic disease caused by cutaneous inoculation of the dimorphic fungus Sporothrix schenckii. The primary lesion can spread and often develop a unilateral lymphocutaneous lesions or, rarely, disseminated disease. We report a lymphangitic sporotrichosis case with ulcerated erythematous nodules distributed bilaterally on the posterior and medical aspect of the both legs, probably due to multiple inoculations. The treatment with oral potassium iodide was satisfactory.

Administration, Oral↗

PubMed2003

Cutaneous sporotrichosis: an unusual clinico-pathologic and therapeutic presentation.

This report presents a number of unusual clinico-histopathologic and therapeutic features in a culture proven case of cutaneous sporotrichosis. These include lymphocutaneous sporotrichosis involving face; its dissemination in an otherwise healthy patient; its histology mimicking cutaneous cryptococcosis; two episodes of severe purulent inflammatory reaction bordering the lesion during therapy with saturated solution of potassium iodide; no therapeutic response to potassium iodide therapy and rapid healing of lesion with high-dose of fluconazole.

Adult↗

PubMed1975

New observations on the epidemiology and pathogenesis of sporotrichosis.

Five uncommon cases of skin sporotrichosis are presented, including a small family outbreak with interesting epidemiological findings and two patients treated with corticosteroids; we attributed the severity of the lesions to the steroids. Mice were used to confirm our hypothesis on the pathogenesis. The pathological findings in case of sporotrichosis in a dog are presented. A group of 359 pulmonary patients was tested with two different antigens of Sporotrichum schenkii.

Adult↗

PubMed1985

Sporotrichosis, a hazard of outdoor work or recreation. Three illustrative cases.

Persons whose work or recreation exposes them to minor trauma out of doors are at risk for sporotrichosis. The disease is generally indolent, with the lymphocutaneous form being by far the commonest. Extracutaneous disease may affect the bones or joints, lungs, or other foci. Isolation of the fungus Sporothrix schenckii from involved tissue establishes the diagnosis. Saturated solution of potassium iodide is the first-line treatment of lymphocutaneous disease. Intravenous amphotericin B is used for lesions not responding to saturated solution of potassium iodide and, occasionally, excision of lesions is required. Amphotericin B also is the treatment of choice for extracutaneous sporotrichosis.

Adult↗